| abstract |
the present invention relates to pharmaceutical compositions comprising (i) an anti-lag-3 antibody or antigen binding fragment thereof or (ii) an anti-lag-3 antibody or antigen binding fragment thereof and a anti-pd-1 antibody, anti-pd-l1 antibody or antigen binding fragment thereof. the present invention also relates to pharmaceutical compositions which comprise a buffering agent, stabilizing or massing agent and a surfactant. the invention also provides a vial, syringe, intravenous bag or kit that comprises the compositions and methods for using the compositions. |